Does Parkinson's Disease Affect Life Expectancy?
At a Glance
Parkinson's disease is not considered fatal itself, but it can slightly reduce life expectancy. People often live 10 to 20 years post-diagnosis, usually passing away from secondary complications like aspiration pneumonia, falls, or unrelated age-related illnesses rather than the disease itself.
In this answer
4 sections
Parkinson’s disease itself is not considered a fatal illness, but it is associated with a somewhat reduced life expectancy compared to the general population [1][2]. People generally do not die directly from Parkinson’s disease; rather, they die with it [3][4]. As the disease advances, late-stage symptoms can increase the risk of secondary complications, which can be life-threatening [1].
Because Parkinson’s typically progresses slowly, it is common for people to live 10, 15, or even 20 or more years after their initial diagnosis, particularly if they are diagnosed earlier in life and do not have other serious health conditions [5]. However, individual survival is highly variable and depends heavily on your specific symptoms and overall health [6].
Dying “With” vs. Dying “From” Parkinson’s
The neurodegenerative process of Parkinson’s damages dopamine-producing neurons, but this specific neurological damage is not what stops the heart or breathing [4]. Instead, the physical symptoms of the disease create vulnerabilities to other health events:
- Aspiration Pneumonia: More than one-third of people with Parkinson’s eventually develop dysphagia, or difficulty swallowing [7]. Dysphagia can allow food, liquids, or saliva to accidentally enter the lungs. This can cause aspiration pneumonia, which is a leading cause of death in people with advanced Parkinson’s disease [2][1]. Working proactively with a speech-language pathologist can help you learn safe swallowing techniques to prevent pneumonia.
- Falls and Fractures: Progressive balance issues, stiffness, and changes in posture increase the likelihood of severe falls, which can lead to debilitating injuries and a subsequent decline in health [5]. Physical therapy and targeted exercise programs are critical for maintaining balance and preventing these falls.
- Unrelated Illnesses: Many people with Parkinson’s pass away from common, age-related conditions—such as cardiovascular disease or strokes—rather than complications of Parkinson’s itself [4][8].
Understanding the Standardized Mortality Ratio (SMR)
When reading medical research about life expectancy, you might encounter a statistical term called the Standardized Mortality Ratio (SMR) [9]. Researchers use this metric to compare the mortality rate of a specific group (like people with Parkinson’s) against the expected mortality of the general public of the exact same age and sex [10].
An SMR of 1.0 means the life expectancy is identical to the general public. Research shows that people with Parkinson’s disease generally have an SMR greater than 1.0, indicating a higher relative risk of passing away sooner [8][9]. However, it is important to know that this is just a broad mathematical average. It does not dictate your individual timeline, nor does it account perfectly for variations in the quality of care or how well you manage your health [11][12].
The Impact of Modern Therapies
Modern treatments, including levodopa medications and Deep Brain Stimulation (DBS), have dramatically transformed symptom management [13][14].
While these therapies do not cure the disease or stop the underlying neurodegeneration, they provide profound relief from movement symptoms like tremors, stiffness, and slow mobility [13]. However, medications and DBS are generally not effective at treating swallowing difficulties, and in some cases, DBS can even complicate speech or swallowing [7].
Because of this, safe swallowing and fall prevention are best managed through allied health professionals, such as physical, occupational, and speech therapists. Regular engagement with a comprehensive medical team is strongly linked to longer survival, as it helps delay the severe complications that can shorten life [15][16].
Factors That Influence Individual Lifespan
Because Parkinson’s disease is highly individualized, life expectancy varies widely. Several factors are associated with how the disease might impact lifespan:
- Age at Diagnosis: Being diagnosed at an older age is linked to a more rapid progression of certain symptoms and a higher mortality risk [5][17]. Conversely, those diagnosed at a younger age typically have a longer timeline with the disease [5].
- Cognitive Health: The onset of mild cognitive impairment or Parkinson’s disease dementia significantly increases the risk of mortality compared to those without cognitive decline [5][18]. While this can be frightening to read, staying physically active, socially engaged, and managing your blood pressure are strongly linked to protecting your long-term brain health.
- Other Health Conditions: Pre-existing health conditions, such as heart disease and diabetes, heavily influence overall life expectancy, sometimes more than the Parkinson’s diagnosis itself [5][14]. Managing your general health remains incredibly important.
Common questions in this guide
Is Parkinson's disease fatal?
How long can you live after a Parkinson's diagnosis?
What do most people with Parkinson's disease die from?
How does age at diagnosis affect Parkinson's life expectancy?
Can medications or DBS improve my life expectancy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my current symptoms, when should I request a formal swallowing evaluation (such as a FEES or MBSS) to proactively monitor for dysphagia?
- 2.What specific physical therapy or targeted exercise programs do you recommend to help me maintain my balance and reduce my fall risk?
- 3.What lifestyle changes or medical interventions do you recommend to help protect my cognitive health over the long term?
- 4.How do my other health conditions, such as high blood pressure or diabetes, interact with my Parkinson's care plan?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (18)
- 1
Motor and non-motor function predictors of mortality in Parkinson's disease.
Bugalho P, Ladeira F, Barbosa R, et al.
Journal of neural transmission (Vienna, Austria : 1996) 2019; (126(11)):1409-1415 doi:10.1007/s00702-019-02055-3.
PMID: 31385098 - 2
Video-fluoroscopic swallowing study scale for predicting aspiration pneumonia in Parkinson's disease.
Tomita S, Oeda T, Umemura A, et al.
PloS one 2018; (13(6)):e0197608 doi:10.1371/journal.pone.0197608.
PMID: 29874285 - 3
Mortality and quality of death certification in a cohort of patients with Parkinson's disease and matched controls in North Wales, UK at 18 years: a community-based cohort study.
Hobson P, Meara J
BMJ open 2018; (8(2)):e018969 doi:10.1136/bmjopen-2017-018969.
PMID: 29444783 - 4
[An analysis of causes of death in patients with Parkinson's disease].
Amosova NA, Smolentseva IG, Маslyuk ОА, et al.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2017; (117(6. Vyp. 2)):70-72 doi:10.17116/jnevro20171176270-72.
PMID: 28980616 - 5
Overall and Disease Related Mortality in Parkinson's Disease - a Longitudinal Cohort Study.
Hoogland J, Post B, de Bie RMA
Journal of Parkinson's disease 2019; (9(4)):767-774 doi:10.3233/JPD-191652.
PMID: 31498129 - 6
Sex-Dependent Improvement in Survival of Parkinson's Disease Patients.
Kuusimäki T, Kurki S, Sipilä JOT, et al.
Movement disorders clinical practice 2020; (7(5)):516-520 doi:10.1002/mdc3.12954.
PMID: 32626796 - 7
The prevalence and associated factors of dysphagia in Parkinson's disease: A systematic review and meta-analysis.
Gong S, Gao Y, Liu J, et al.
Frontiers in neurology 2022; (13()):1000527 doi:10.3389/fneur.2022.1000527.
PMID: 36277913 - 8
All-Cause and Cause-Specific Mortality in Parkinson's Disease: A Meta-Analysis.
Lee YH, Song GG
Neuroepidemiology 2025; 1-12 doi:10.1159/000546136.
PMID: 40300576 - 9
Survival following liver transplantation: A population-based nested case-control study.
Cotton JL, Suarez-Pierre A, Breithaupt JJ, et al.
American journal of surgery 2024; (228()):264-272 doi:10.1016/j.amjsurg.2023.10.039.
PMID: 38867471 - 10
Indirect standardization for rare events and a dynamic standard population rate: An analysis and simulation of U.S. military suicide mortality rates.
Smolenski DJ, Balcena PP, Tucker J, Curry JC
Suicide & life-threatening behavior 2021; (51(6)):1159-1174 doi:10.1111/sltb.12798.
PMID: 34415634 - 11
Major trauma care in Hong Kong and Germany: a trauma registry data benchmark study.
Lai CY, Maegele M, Yeung JHH, et al.
European journal of trauma and emergency surgery : official publication of the European Trauma Society 2021; (47(5)):1581-1590 doi:10.1007/s00068-020-01311-6.
PMID: 32128612 - 12
Can we trust the standardized mortality ratio? A formal analysis and evaluation based on axiomatic requirements.
Roessler M, Schmitt J, Schoffer O
PloS one 2021; (16(9)):e0257003 doi:10.1371/journal.pone.0257003.
PMID: 34492062 - 13
Long-term outcomes of deep brain stimulation in Parkinson disease.
Limousin P, Foltynie T
Nature reviews. Neurology 2019; (15(4)):234-242 doi:10.1038/s41582-019-0145-9.
PMID: 30778210 - 14
Long-Term Mortality and 10-Year Outcomes after Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease.
Kamo H, Oyama G, Shimizu M, et al.
Stereotactic and functional neurosurgery 2026; 1-11 doi:10.1159/000550490.
PMID: 41553954 - 15
Effects of physician visit frequency for Parkinson's disease treatment on mortality, hospitalization, and costs: a retrospective cohort study.
Fujita T, Babazono A, Kim SA, et al.
BMC geriatrics 2021; (21(1)):707 doi:10.1186/s12877-021-02685-x.
PMID: 34911495 - 16
Comprehensive effects of Parkinson's disease multimodal complex treatment (PD-MCT): a two-center prospective trial.
Friedrich I, Gutschow L, Weise D, et al.
Journal of neurology 2026; (273(2)):150.
PMID: 41709020 - 17
Cerebral cortical thinning in Parkinson's disease depends on the age of onset.
Seo K, Matunari I, Yamamoto T
PloS one 2023; (18(2)):e0281987 doi:10.1371/journal.pone.0281987.
PMID: 36809440 - 18
Relative survival in patients with dementia with Lewy bodies and Parkinson's disease dementia.
Larsson V, Torisson G, Londos E
PloS one 2018; (13(8)):e0202044 doi:10.1371/journal.pone.0202044.
PMID: 30096198
This page provides informational content about Parkinson's disease life expectancy and complications. It does not replace professional medical advice or personalized prognosis from your neurologist and healthcare team.
Get notified when new evidence is published on Parkinson's Disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.